Literature DB >> 8909172

Venlafaxine hydrochloride and chronic pain.

K Taylor1, M C Rowbotham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8909172      PMCID: PMC1303727     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  2 in total

1.  Venlafaxine: a new dimension in antidepressant pharmacotherapy.

Authors: 
Journal:  J Clin Psychiatry       Date:  1993-03       Impact factor: 4.384

2.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Authors:  M B Max; S A Lynch; J Muir; S E Shoaf; B Smoller; R Dubner
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

  2 in total
  8 in total

Review 1.  Antidepressants as analgesics: a review of randomized controlled trials.

Authors:  M E Lynch
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

Review 2.  The pharmacotherapy of chronic pain: a review.

Authors:  Mary E Lynch; C Peter N Watson
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

Review 3.  Antidepressants in the management of cancer pain.

Authors:  T A Mays
Journal:  Curr Pain Headache Rep       Date:  2001-06

Review 4.  Preventive analgesia and novel strategies for the prevention of chronic post-surgical pain.

Authors:  Hance Clarke; Michael Poon; Aliza Weinrib; Rita Katznelson; Kirsten Wentlandt; Joel Katz
Journal:  Drugs       Date:  2015-03       Impact factor: 9.546

Review 5.  Treatment of postherpetic neuralgia: an update.

Authors:  G E Kanazi; R W Johnson; R H Dworkin
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

6.  A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.

Authors:  Charles H Bombardier; Jesse R Fann; Catherine S Wilson; Allen W Heinemann; J Scott Richards; Ann Marie Warren; Larry Brooks; Catherine A Warms; Nancy R Temkin; Denise G Tate
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

Review 7.  Pharmacological management of postherpetic neuralgia.

Authors:  Marco Pappagallo; E Joseph Haldey
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 8.  What is new in neuropathic pain?

Authors:  Mellar P Davis
Journal:  Support Care Cancer       Date:  2006-11-28       Impact factor: 3.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.